I’ve been reading a lot of posts lately about people microdosing everything from BPC-157 to TB-500, and I keep coming back to the same question: what are we actually tracking to judge effectiveness? With full protocols you can look at healing time, inflammation markers, or functional outcomes. But …
Microdosing peptides – what are we actually measuring?
The full discussion is open to members. Reading along is free.